Psychiatric Drugs Explained
7th Edition
Published on 6. May 2022
Book
Paperback/Softback
356 pages
978-0-7020-8390-7 (ISBN)
Description
Psychiatric Drugs Explained offers a wealth of evidence-based information on psychiatric drugs in an easy-to-use format that can be quickly referenced in the clinical setting.
Written by internationally recognised author Dr David Healy, the book provides a comprehensive review of drug effects, action and side-effects. There is an emphasis on the lived experience of patients, providing the reader with a sense of what the adverse effects of drugs might feel like to those who use them.
A reader-friendly approach and clear layout, with information organised by disorder, make this popular title accessible and useful not only to nursing staff, but to all members of the multidisciplinary team.
Quick reference guide suitable for all members of the multidisciplinary team
Helpful boxes on user issues make potential complications easy to spot
Distinctive, reader-friendly style helps the reader understand the benefits and impacts of psychotropic drugs
New topics include management of dependence disorders, stimulants and drugs for children, cognitive impairment and sleep disorders
The only book with detailed coverage of the sexual side effects of psychiatric drugs and the abusive prescribing of prescription drugs
Written by internationally recognised author Dr David Healy, the book provides a comprehensive review of drug effects, action and side-effects. There is an emphasis on the lived experience of patients, providing the reader with a sense of what the adverse effects of drugs might feel like to those who use them.
A reader-friendly approach and clear layout, with information organised by disorder, make this popular title accessible and useful not only to nursing staff, but to all members of the multidisciplinary team.
Quick reference guide suitable for all members of the multidisciplinary team
Helpful boxes on user issues make potential complications easy to spot
Distinctive, reader-friendly style helps the reader understand the benefits and impacts of psychotropic drugs
New topics include management of dependence disorders, stimulants and drugs for children, cognitive impairment and sleep disorders
The only book with detailed coverage of the sexual side effects of psychiatric drugs and the abusive prescribing of prescription drugs
More details
Edition
7th edition
Language
English
Place of publication
London
United Kingdom
Target group
College/higher education
Illustrations
5 illustrations; Illustrations
Dimensions
Height: 151 mm
Width: 229 mm
Thickness: 15 mm
Weight
580 gr
ISBN-13
978-0-7020-8390-7 (9780702083907)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Previous edition
David Healy
Psychiatric Drugs Explained
Book
04/2016
6th Edition
Churchill Livingstone
€54.65
Article exhausted; check for reprint
Person
A professor of Psychiatry in Wales, David studied medicine in Dublin, and at Cambridge University. He is a former Secretary of the British Association for Psychopharmacology, and has authored more than 200 peer-reviewed articles, 200 other pieces, and 20 books, including The Antidepressant Era and The Creation of Psychopharmacology from Harvard University Press, The Psychopharmacologists Volumes 1-3 and Let Them Eat Prozac from New York University Press, and Mania from Johns Hopkins University Press.
David's latest book, Pharmageddon, documents the riveting and terrifying story of how pharmaceutical companies have hijacked healthcare in America and the life-threatening results.
David's main areas of research are clinical trials in psychopharmacology, the history of psychopharmacology, and the impact of both trials and psychotropic drugs on our culture.
David's latest book, Pharmageddon, documents the riveting and terrifying story of how pharmaceutical companies have hijacked healthcare in America and the life-threatening results.
David's main areas of research are clinical trials in psychopharmacology, the history of psychopharmacology, and the impact of both trials and psychotropic drugs on our culture.
Content
Section 1 Management of the psychoses
2 The antipsychotics
3 Antipsychotic side effects and their management
References
Section 2 Management of depression
4 The antidepressants
5 Side effects of antidepressants
References
Section 3 Management of bipolar disorders
6 Management of acute bipolar disorder
7 Mood-stabilisers
References
Section 4 Stimulants & Drugs for children
8 Stimulants & Drugs for children
References
Section 5 Management of anxiety
8 The anxiety disorders
10 Benzodiazepine anxiolytics
11 Anxiolysis and the serotonin system
12 Beta-blockers and anxiety
References
Section 6 Management of sleep disorders and insomnia
13 Sleep disorders and insomnia
14 Non-pharmacological management of insomnia
15 Hypnotics
16 Sedatives
References
Section 7 Management of cognitive impairment
17 Cognitive enhancement and the dementias
18 Cognitive enhancement and neuroprotection
References
Section 8 Management of sexual difficulties
19 The range of sexual difficulties
20 Effects of drugs on aspects of sexual functioning
Appendix 20.1 Male sexual functioning questionnaire
Appendix 20.2 Female sexual functioning questionnaire
References
Section 9 Management of dependence and withdrawal
21 Dependence & Withdrawal
22 Dependence & Craving
23 Dependence & Protracted Withdrawal
References
Section 10 Consent, abuse and liability
24 Consent
25 Pharmacological abuse
References
Section 11 The marketing of tranquillity
26 The ethical industry
27 Evidence-biased care
28 Marketing & Risk
29 From healthcare to pharmageddon
2 The antipsychotics
3 Antipsychotic side effects and their management
References
Section 2 Management of depression
4 The antidepressants
5 Side effects of antidepressants
References
Section 3 Management of bipolar disorders
6 Management of acute bipolar disorder
7 Mood-stabilisers
References
Section 4 Stimulants & Drugs for children
8 Stimulants & Drugs for children
References
Section 5 Management of anxiety
8 The anxiety disorders
10 Benzodiazepine anxiolytics
11 Anxiolysis and the serotonin system
12 Beta-blockers and anxiety
References
Section 6 Management of sleep disorders and insomnia
13 Sleep disorders and insomnia
14 Non-pharmacological management of insomnia
15 Hypnotics
16 Sedatives
References
Section 7 Management of cognitive impairment
17 Cognitive enhancement and the dementias
18 Cognitive enhancement and neuroprotection
References
Section 8 Management of sexual difficulties
19 The range of sexual difficulties
20 Effects of drugs on aspects of sexual functioning
Appendix 20.1 Male sexual functioning questionnaire
Appendix 20.2 Female sexual functioning questionnaire
References
Section 9 Management of dependence and withdrawal
21 Dependence & Withdrawal
22 Dependence & Craving
23 Dependence & Protracted Withdrawal
References
Section 10 Consent, abuse and liability
24 Consent
25 Pharmacological abuse
References
Section 11 The marketing of tranquillity
26 The ethical industry
27 Evidence-biased care
28 Marketing & Risk
29 From healthcare to pharmageddon